99 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
or long-term indebtedness of the Company or its subsidiaries and there has been no dividend or distribution of any kind declared, paid or made … , incentive or benefit plan, share purchase or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award under the rules
8-K
EX-99.1
5cc5yrz0lbsd8
8 Nov 23
Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update
5:18pm
8-K
EX-99.2
14f894dsx63m eg
11 Oct 23
Entry into a Material Definitive Agreement
8:13am
8-K
obm2gjxwgvig
11 Oct 23
Entry into a Material Definitive Agreement
8:13am
DEFA14A
c1mec
9 May 22
Additional proxy soliciting materials
8:01am
8-K
EX-10.1
8y8bs woof5792ijt
2 May 22
Tempest Announces Private Placement Financing of $15 Million
8:02am
PRE 14A
5u996wy
22 Apr 22
Preliminary proxy
4:01pm
8-K
EX-1.1
sraxsope9dl3i9xh
23 Jul 21
Other Events
5:20pm